Sanofi reportedly offers $67 to $70 per share for Genzyme

Tuesday 3 August 2010

Sanofi-Aventis SA has reportedly offered between $67 and $70 per share for Genzyme Corp in what amounts to a friendly acquisition proposal, according to a report in the 3 August 2010 edition of the Wall Street Journal.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States